ASST Papa Giovanni XXIII — Bergamo

Public research footprint of ASST Papa Giovanni XXIII, compiled from the ClinicalTrials.gov public registry.

277

Registered studies

128

Active

Recruiting now

108

Completed

Stopped or withdrawn

Most-studied conditions

AChR-Ab Seropositive Generalized Myasthenia Gravis · Generalized Myasthenia Gravis (gMG) · Heart Failure · Relapsed B-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT04624230 — Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate… (Active Not Recruiting)
NCT06852222 — A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ASST Papa Giovanni XXIII?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.